AGENUS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
AGENUS INC (AGEN) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-07
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $318.00K, a 82.93% decline year-over-year.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-30 was $69.00K.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was $387.00K, a 90.21% decline from fiscal 2024.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was $3.95M, a 611.15% increase from fiscal 2023.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $556.00K, a 31.78% decline from fiscal 2022.
- AGENUS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $815.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $318.00K derived: sum of 2 quarters · filed 2026-03-16 | $387.00K derived: sum of 3 quarters · filed 2026-08-07 | $387.00K 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $318.00K 10-Q · filed 2025-11-10 | $387.00K derived: sum of 2 quarters · filed 2026-08-07 | $387.00K 10-Q · filed 2025-11-10 | |||||
| 2025-06-30 | $69.00K 10-Q · filed 2026-08-07 | $69.00K 10-Q · filed 2026-08-07 | ||||||
| 2024-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.95M derived: sum of 2 quarters · filed 2026-03-16 | $3.95M derived: sum of 3 quarters · filed 2026-03-16 | $3.95M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $1.86M 10-Q · filed 2025-11-10 | $1.86M derived: sum of 2 quarters · filed 2025-11-10 | $1.86M 10-Q · filed 2025-11-10 | $2.02M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $158.00K derived: sum of 3 quarters · filed 2026-03-16 | $158.00K derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $158.00K derived: sum of 2 quarters · filed 2026-03-16 | $158.00K derived: sum of 3 quarters · filed 2026-03-16 | $150.00K derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $158.00K derived: sum of 2 quarters · filed 2026-03-16 | $150.00K derived: sum of 3 quarters · filed 2026-03-16 | $556.00K 10-K · filed 2026-03-16 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$8.00K derived: sum of 2 quarters · filed 2024-11-12 | $398.00K 10-Q · filed 2024-11-12 | $263.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$8.00K 10-Q · filed 2024-08-08 | $398.00K 10-Q · filed 2024-08-08 | $263.00K derived: sum of 3 quarters · filed 2025-03-17 | $270.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $406.00K 10-Q · filed 2024-05-07 | $271.00K derived: sum of 2 quarters · filed 2025-03-17 | $278.00K derived: sum of 3 quarters · filed 2025-03-17 | $685.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$128.00K derived: sum of 2 quarters · filed 2025-03-17 | $279.00K derived: sum of 3 quarters · filed 2025-03-17 | $815.00K 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $7.00K 10-Q · filed 2023-11-09 | $414.00K derived: sum of 2 quarters · filed 2023-11-09 | $950.00K 10-Q · filed 2023-11-09 | $3.00M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | $407.00K 10-Q · filed 2023-08-08 | $943.00K 10-Q · filed 2023-08-08 | $2.99M derived: sum of 3 quarters · filed 2024-03-14 | $2.72M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $536.00K 10-Q · filed 2023-05-09 | $2.59M derived: sum of 2 quarters · filed 2024-03-14 | $2.31M derived: sum of 3 quarters · filed 2024-03-14 | -$11.99M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.77M derived: sum of 2 quarters · filed 2024-03-14 | -$12.53M derived: sum of 3 quarters · filed 2024-03-14 | -$11.48M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | -$275.00K 10-Q · filed 2022-11-08 | -$14.57M derived: sum of 2 quarters · filed 2022-11-08 | -$13.53M 10-Q · filed 2022-11-08 | -$10.10M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | -$14.30M 10-Q · filed 2022-08-09 | -$13.26M 10-Q · filed 2022-08-09 | -$9.82M derived: sum of 3 quarters · filed 2023-03-16 | -$12.02M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $1.04M 10-Q · filed 2022-05-10 | $4.47M derived: sum of 2 quarters · filed 2023-03-16 | $2.28M derived: sum of 3 quarters · filed 2023-03-16 | -$4.56M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.24M derived: sum of 2 quarters · filed 2023-03-16 | -$5.61M derived: sum of 3 quarters · filed 2023-03-16 | -$1.22M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$2.20M 10-Q · filed 2021-11-09 | -$9.04M derived: sum of 2 quarters · filed 2021-11-09 | -$4.65M 10-Q · filed 2021-11-09 | -$9.28M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$6.84M 10-Q · filed 2021-08-09 | -$2.46M 10-Q · filed 2021-08-09 | -$7.08M derived: sum of 3 quarters · filed 2022-03-01 | -$5.30M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $4.38M 10-Q · filed 2021-05-07 | -$241.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.54M derived: sum of 3 quarters · filed 2022-03-01 | $1.33M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.84M derived: sum of 2 quarters · filed 2022-03-01 | -$3.06M derived: sum of 3 quarters · filed 2022-03-01 | -$5.80M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $1.78M 10-Q · filed 2020-11-09 | $1.57M derived: sum of 2 quarters · filed 2020-11-09 | -$1.18M 10-Q · filed 2020-11-09 | -$1.30M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-06-30 | -$213.00K 10-Q · filed 2020-08-10 | -$2.96M 10-Q · filed 2020-08-10 | -$3.08M derived: sum of 3 quarters · filed 2021-03-16 | -$2.90M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-03-31 | -$2.75M 10-Q · filed 2020-05-11 | -$2.87M derived: sum of 2 quarters · filed 2021-03-16 | -$2.69M derived: sum of 3 quarters · filed 2021-03-16 | $3.60M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $59.00K derived: sum of 2 quarters · filed 2021-03-16 | $6.35M derived: sum of 3 quarters · filed 2021-03-16 | $1.33M 10-K · filed 2021-03-16 | ||||
| 2018-09-30 | $180.00K 10-Q · filed 2019-11-07 | $6.47M derived: sum of 2 quarters · filed 2019-11-07 | $1.46M 10-Q · filed 2019-11-07 | $4.77M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $6.29M 10-Q · filed 2019-08-09 | $1.28M 10-Q · filed 2019-08-09 | $4.59M derived: sum of 3 quarters · filed 2020-03-16 | $3.40M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | -$5.02M 10-Q · filed 2019-05-10 | -$1.71M derived: sum of 2 quarters · filed 2020-03-16 | -$2.89M derived: sum of 3 quarters · filed 2020-03-16 | -$2.02M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.13M derived: sum of 2 quarters · filed 2020-03-16 | $2.99M derived: sum of 3 quarters · filed 2020-03-16 | $3.19M 10-K · filed 2020-03-16 | ||||
| 2017-09-30 | -$1.18M 10-Q · filed 2018-11-07 | -$319.00K derived: sum of 2 quarters · filed 2018-11-07 | -$123.00K 10-Q · filed 2018-11-07 | $9.28M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $865.00K 10-Q · filed 2018-08-09 | $1.06M 10-Q · filed 2018-08-09 | $10.46M derived: sum of 3 quarters · filed 2019-03-18 | -$513.00K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $196.00K 10-Q · filed 2018-05-10 | $9.60M derived: sum of 2 quarters · filed 2019-03-18 | -$1.38M derived: sum of 3 quarters · filed 2019-03-18 | -$2.10M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.57M derived: sum of 2 quarters · filed 2019-03-18 | -$2.29M derived: sum of 3 quarters · filed 2019-03-18 | -$1.95M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | -$10.97M 10-Q · filed 2017-11-07 | -$11.70M derived: sum of 2 quarters · filed 2017-11-07 | -$11.35M 10-Q · filed 2017-11-07 | -$10.73M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | -$721.00K 10-Q · filed 2017-08-07 | -$379.00K 10-Q · filed 2017-08-07 | $244.00K derived: sum of 3 quarters · filed 2018-03-16 | $7.24M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $342.00K 10-Q · filed 2017-05-04 | $965.00K derived: sum of 2 quarters · filed 2018-03-16 | $7.96M derived: sum of 3 quarters · filed 2018-03-16 | $1.18M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $623.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $7.62M derived: sum of 2 quarters · filed 2018-03-16 | $834.00K derived: sum of 3 quarters · filed 2018-03-16 | -$6.70M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $6.99M 10-Q · filed 2016-11-09 | $211.00K derived: sum of 2 quarters · filed 2016-11-09 | -$7.33M 10-Q · filed 2016-11-09 | -$13.86M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$6.78M 10-Q · filed 2016-08-04 | -$14.32M 10-Q · filed 2016-08-04 | -$20.69M 10-Q · filed 2015-08-03 | -$20.86M derived: sum of 3 quarters · filed 2017-03-16 | -$19.89M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$7.54M 10-Q · filed 2016-05-09 | -$7.06M 10-Q · filed 2015-05-01 | -$14.07M derived: sum of 2 quarters · filed 2017-03-16 | -$13.10M derived: sum of 3 quarters · filed 2017-03-16 | -$11.49M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$5.57M derived: sum of 2 quarters · filed 2017-03-16 | -$3.95M derived: sum of 3 quarters · filed 2017-03-16 | -$6.70M 10-K · filed 2017-03-16 | -$3.58M 10-K · filed 2015-03-16 | |||
| 2014-09-30 | $969.00K 10-Q · filed 2015-11-04 | $2.59M derived: sum of 2 quarters · filed 2015-11-04 | -$164.00K 10-Q · filed 2015-11-04 | $10.65M 10-Q · filed 2014-10-31 | $11.99M derived: sum of 4 quarters · filed 2015-11-04 | |||
| 2014-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $10.51M 10-Q · filed 2015-08-03 | $11.03M derived: sum of 3 quarters · filed 2015-08-03 | $10.51M derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-03-31 | $8.89M 10-Q · filed 2015-05-01 | $9.41M derived: sum of 2 quarters · filed 2015-05-01 | $8.89M derived: sum of 3 quarters · filed 2015-05-01 | $8.89M derived: sum of 4 quarters · filed 2015-05-01 | ||||
| 2013-12-31 | $512.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | -$512.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$512.39K derived: sum of 2 quarters · filed 2014-10-31 | -$512.39K 10-Q · filed 2014-10-31 | $512.39K 10-Q · filed 2013-11-08 | -$512.39K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |